These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22686341)

  • 21. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
    Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
    J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theoretical dissolution model of poly-disperse drug particles in biorelevant media.
    Okazaki A; Mano T; Sugano K
    J Pharm Sci; 2008 May; 97(5):1843-52. PubMed ID: 17828749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advancements in mechanical reduction methods: particulate systems.
    Leleux J; Williams RO
    Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a standardized dissolution test method for inhaled pharmaceutical formulations.
    Son YJ; McConville JT
    Int J Pharm; 2009 Dec; 382(1-2):15-22. PubMed ID: 19665533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Miniaturization of powder dissolution measurement and estimation of particle size.
    Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
    Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Diffusion-Controlled Dissolution from Polydisperse Collections of Drug Particles with an Assessed Mathematical Model.
    Wang Y; Abrahamsson B; Lindfors L; Brasseur JG
    J Pharm Sci; 2015 Sep; 104(9):2998-3017. PubMed ID: 25989144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution characteristics of cylindrical particles and tablets.
    Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
    Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical technologies for real-time drug dissolution and precipitation testing on a small scale.
    Kuentz M
    J Pharm Pharmacol; 2015 Feb; 67(2):143-59. PubMed ID: 24834963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel analytical methods for the characterization of oral wafers.
    Garsuch V; Breitkreutz J
    Eur J Pharm Biopharm; 2009 Sep; 73(1):195-201. PubMed ID: 19482082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dissolution rates of SiO2 nanoparticles as a function of particle size.
    Diedrich T; Dybowska A; Schott J; Valsami-Jones E; Oelkers EH
    Environ Sci Technol; 2012 May; 46(9):4909-15. PubMed ID: 22482930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C; D'Souza SS; Parker JE; Mirza T
    Pharm Res; 2007 Sep; 24(9):1603-7. PubMed ID: 17385013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
    Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
    Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Importance of particle size decrease in the preformulation].
    Szunyogh T; Ambrus R; Szabóné RP
    Acta Pharm Hung; 2011; 81(1):29-36. PubMed ID: 21595303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational oral absorption simulation of free base drugs.
    Sugano K
    Int J Pharm; 2010 Oct; 398(1-2):73-82. PubMed ID: 20655999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.